AVGO vs CAH Stock Comparison
AVGO currently leads CAH in this stock comparison, with AIQ scores of 52 vs 51. The clearest difference is quality, while CAH has the stronger momentum profile.
What is the main difference between AVGO and CAH?
AVGO leads the current stock comparison as Broadcom Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Broadcom Inc. vs Cardinal Health, Inc.
AVGO leads
AVGO leads by 1 AIQ points, primarily on Quality.
Fragile: 2 of 6 evidence groups support AVGO, and its current signal state is conflicted.
Broadcom Inc.
Cardinal Health, Inc.
The Algovestiq AIQ Score currently favors AVGO over CAH, 52 versus 51 as of Oct 31, 2026. AVGO's advantage is driven primarily by stronger quality, while CAH holds the stronger momentum profile. AVGO also shows the weaker technical structure relative to its 50-day moving average. 2 of 6 covered evidence groups favor AVGO today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 1 points. AVGO lead: Stable — the AIQ differential has held near 1 points over 30 sessions.
Compare Broadcom Inc. and Cardinal Health, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare AVGO and CAH against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Quality85 vs 32AVGO +53
- Momentum40 vs 67CAH +27
- Value30 vs 56CAH +26
- Risk Resilience51 vs 55CAH +4
2 of 6 evidence groups favor AVGO. AVGO’s edge is concentrated in quality; CAH keeps a meaningful momentum edge.
What changed since the last close
Latest scored session 2026-10-30, compared against the prior scored session 2026-10-29.
No factor moved materially.
No signal started or stopped since the prior session; its 3 active signals are unchanged.
No factor moved materially.
No signal started or stopped since the prior session; its 4 active signals are unchanged.
AVGO's lead was unchanged in the latest session.
Deeper signal detail for each name lives on its own signals page — AVGO and CAH both carry a full feed there.
The central trade-off
AVGO (Broadcom Inc.): the stronger current systematic profile, led by quality.
CAH (Cardinal Health, Inc.): the counter-case, on momentum, value, risk resilience.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
AVGOAVGO on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
AVGOAVGO on combined revenue and EPS growth.
Value
CAHCAH on the peer-relative Value factor, by 26 points.
Momentum
CAHCAH on the Momentum factor, by 27 points.
Lower downside
CAHCAH on Risk Resilience, by 4 points.
Analyst upside
AVGOAVGO on implied upside to the consensus price target.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | AVGO | CAH | Note |
|---|---|---|---|
| Implied upside to target | +55.3% | +10.1% | AVGO has more room |
| Target dispersion | +49.4% | +16.3% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 19 | 9 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
Dividend growth
| Dividend metric | AVGO | CAH |
|---|---|---|
| 5Y dividend CAGR | 12.63% | 0.95% |
| 2020 regular DPS | $1.335 | $1.939 |
| 2025 regular DPS | $2.420 | $2.033 |
| Years increased | 5 | 4 |
| No cut in window | Yes | No (1) |
| Cohort rank | #55 | not ranked |
AVGO grew its split-adjusted regular dividend faster over 2020–2025 — 12.63% a year against CAH's 0.95%. AVGO never reduced its regular dividend in the window; CAH did in 1 year.
Yield and payout ratio shown elsewhere on this page are current values, not part of the study window.
Split-adjusted regular dividends per share, 2020–2025, excluding special dividends. Research as of Sep 19, 2026.
AIQ Agreement Matrix
2 of 6 covered evidence groups favor AVGO. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | Even | 52 vs 51 |
| Fundamentals | AVGO | revenue growth 14.9% vs 4.8%; EPS growth 26.5% vs 1.2%; TTM ROE 36.4% vs -59.7%; gross margin 67% vs 3.8%; operating margin 43.7% vs 1% |
| Valuation | CAH | Value 30 vs 56 |
| Technicals | CAH | Price vs 50-day -7.9% vs 5.7%; vs 200-day -4.3% vs 10.4% |
| Risk Resilience | CAH | Risk Resilience 51 vs 55 |
| Analyst expectations | AVGO | Target upside 55.3% vs 10.1% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of AVGO and CAH and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is narrow at 1 points. (argues the conclusion is provisional)
- Only 2 of 6 covered evidence groups agree. (argues the conclusion is provisional)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
- Signal direction runs against the verdict: the leader is net-bearish while the laggard is net-bullish. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on AVGO.
How the comparison changed
120 daily snapshots · Jul 1 – Oct 30AVGO lead: Stable — the AIQ differential has held near 1 points over 30 sessions.
- Today
- AVGO +1
- 52 vs 51
- 7 sessions ago
- CAH +10
- 46 vs 56
- 30 sessions ago
- Level
- 55 vs 55
- 90 sessions ago
- CAH +4
- 45 vs 49
The lead changed hands 7 times in this window, most recently on Oct 28 when AVGO moved ahead of CAH.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
1 bullish / 2 bearish, conflicted
Only AVGO
- Death Cross Active — bearish, trend, long horizon (3.92%)
- Downtrend Structure Active — bearish, trend, long horizon
- MACD Bullish Crossover — bullish, momentum, short horizon
3 bullish / 1 bearish, conflicted
Only CAH
- Golden Cross Active — bullish, trend, long horizon (6.88%)
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- Uptrend Structure Active — bullish, trend, long horizon
- MACD Bearish Crossover — bearish, momentum, short horizon
AVGO leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -5.48%, AIQ 0 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.24%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1CAH closes the Quality gap — currently 53 points behind, the largest single contributor to AVGO's edge.
- 2CAH generates a confirmed bullish trend signal it does not currently carry, such as MACD Bullish Crossover.
- 3AVGO's conflicting signal state resolves bearish — it currently carries 1 bullish and 2 bearish rules at once.
- 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
AVGO leads on balance| Metric | AVGO | CAH |
|---|---|---|
| Revenue growth (YoY) | 14.9% | 4.8% |
| EPS growth (YoY) | 26.5% | 1.2% |
| Gross margin | 67% | 3.8% |
| Operating margin | 43.7% | 1% |
| Return on equity (TTM) | 36.4% | -59.7% |
| Debt to equity | 0.74 | -3.45 |
Performance
CAH leads 5 of 6 windows| Metric | AVGO | CAH |
|---|---|---|
| 1 week (5 sessions) | 4.1% | -4.9% |
| 1 month (20 sessions) | 0.2% | 10% |
| 3 months (63 sessions) | -9.3% | 7.8% |
| 6 months (126 sessions) | -13.2% | 20.7% |
| Year to date | 1.6% | 19.1% |
| 1 year (252 sessions) | -0.7% | 51.2% |
Technicals
CAH has the stronger structure| Metric | AVGO | CAH |
|---|---|---|
| RSI (14) | 45.6 | 57.1 |
| ADX (14) | 24.1 | 22.1 |
| Price vs 50-day | -7.9% | 5.7% |
| Price vs 200-day | -4.3% | 10.4% |
| Volatility (1M, annualized) | 43% | 26.8% |
Risk
CAH is the more resilient| Metric | AVGO | CAH |
|---|---|---|
| Beta | 2.18 | -0.12 |
| Sharpe ratio | 0.02 | 1.39 |
| Sortino ratio | 0.03 | 2.56 |
| Max drawdown | -33.2% | -20.6% |
| Current drawdown | -26.9% | -5% |
| Annualized volatility | 46% | 29.9% |
| Value at risk (95%) | -4.4% | -2.5% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, AVGO or CAH?
On the Algovestiq AIQ Score, AVGO is the stronger of the two as of Oct 31, 2026, scoring 52 against CAH's 51. The edge comes from quality. CAH is not without a case — it holds the better momentum profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is AVGO or CAH the better buy right now?
AVGO carries the stronger systematic profile as of Oct 31, 2026, and the comparison is rated Fragile — 2 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 1 points. Treat the lead as provisional.
Why does the AIQ Score favor AVGO over CAH?
The composite weights Quality, Value, Momentum and Risk Resilience. AVGO leads Quality by 53 points; CAH leads Momentum by 27 points; CAH leads Value by 26 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, AVGO or CAH?
Analyst price targets imply +55.3% upside for AVGO and +10.1% for CAH, so the Street currently favors AVGO. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, AVGO or CAH?
CAH is the better-valued of the two on the peer-relative Value factor. CAH on the peer-relative Value factor, by 26 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, AVGO or CAH?
AVGO on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, AVGO or CAH?
CAH on the Momentum factor, by 27 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, AVGO or CAH?
CAH is the more resilient of the two, so the other name carries the higher downside risk. CAH on Risk Resilience, by 4 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is AVGO more profitable than CAH?
AVGO leads on the comparable margin measures — gross margin 67% vs 3.8%; operating margin 43.7% vs 1%; ttm roe 36.4% vs -59.7%.
Is AVGO's lead over CAH getting stronger or weaker?
AVGO lead: Stable — the AIQ differential has held near 1 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-07-01 and 2026-10-30. The lead has changed hands 7 times in that window, most recently on 2026-10-28, when AVGO moved ahead of CAH.
What would change the AVGO vs CAH verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: CAH closes the Quality gap — currently 53 points behind, the largest single contributor to AVGO's edge; CAH generates a confirmed bullish trend signal it does not currently carry, such as MACD Bullish Crossover; AVGO's conflicting signal state resolves bearish — it currently carries 1 bullish and 2 bearish rules at once; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
What do the current signals say about AVGO and CAH?
AVGO: 1 bullish / 2 bearish, conflicted. CAH: 3 bullish / 1 bearish, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on AVGO is Death Cross Active (bearish, long horizon). On CAH it is Golden Cross Active (bullish, long horizon).
Compare AVGO and CAH with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.